Gordon W. Laurie

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Cell Biology
Google:
"Gordon Laurie"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Justis BM, Coburn CE, Tyler EM, et al. (2020) Development of a Quantitative Immunoassay for Tear Lacritin Proteoforms. Translational Vision Science & Technology. 9: 13
Dias-Teixeira K, Horton X, McKown R, et al. (2020) The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease. Advances in Experimental Medicine and Biology. 1221: 747-757
Karnati R, Talla V, Peterson K, et al. (2015) Lacritin and other autophagy associated proteins in ocular surface health. Experimental Eye Research
Wang W, Jashnani A, Aluri SR, et al. (2015) A thermo-responsive protein treatment for dry eyes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 199: 156-67
McKown RL, Coleman Frazier EV, Zadrozny KK, et al. (2014) A cleavage-potentiated fragment of tear lacritin is bactericidal. The Journal of Biological Chemistry. 289: 22172-82
Feng MM, Baryla J, Liu H, et al. (2014) Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro. Current Eye Research. 39: 604-10
Karnati R, Laurie DE, Laurie GW. (2013) Lacritin and the tear proteome as natural replacement therapy for dry eye. Experimental Eye Research. 117: 39-52
Wang N, Zimmerman K, Raab RW, et al. (2013) Lacritin rescues stressed epithelia via rapid forkhead box O3 (FOXO3)-associated autophagy that restores metabolism. The Journal of Biological Chemistry. 288: 18146-61
Zhang Y, Wang N, Raab RW, et al. (2013) Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity. The Journal of Biological Chemistry. 288: 12090-101
Velez V F, Romano JA, McKown RL, et al. (2013) Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity. Investigative Ophthalmology & Visual Science. 54: 2123-32
See more...